The pharmacodynamic and pharmacokinetic differences of the D- and L-isomers of verapamil: Implications in the treatment of paroxysmal supraventricular tachycardia-Reference-Cited by-同舟云学术

The pharmacodynamic and pharmacokinetic differences of the D- and L-isomers of verapamil: Implications in the treatment of paroxysmal supraventricular tachycardia

Published:1986-08 Issue:2 Volume:112 Page:396-403
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Hoon Timothy J.,Bauman Jerry L.,Rodvold Keith A.,Gallestegui Jose,Hariman Robert J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. The influence of stereochemical factors on drug disposition;Jenner;Drug Metab Rev,1973

2. Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil;Raschack;Naunyn Schmiedebergs Arch Pharmacol,1976

3. Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials;Bayer;Naunyn Schmiedebergs Arch Pharmacol,1975

4. Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A review;Mitchell;Am J Cardiol,1982

5. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes;Kawai;Circulation,1981

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ca2+ Channel Inhibitors;Reference Module in Biomedical Sciences;2021

2. Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective;Mini-Reviews in Medicinal Chemistry;2017-12-08

3. Metabolism of amino acids differs in the brains of Djungarian hamster (P. sungorus) and Roborovskii hamster (P. roborovskii);SpringerPlus;2014-06-02

4. Therapie kardiovaskulärer Erkrankungen;Praktische Arzneitherapie;2003

5. Validation of targets and drug candidates in an engineered three-dimensional cardiac tissue model;Drug Discovery Today;2002-04